Abstract
Environmental factors have long been known to play a role in the pathogenesis of congenital heart disease (CHD), but this has not been a major focus of research in the modern era. Studies of human exposures and animal models demonstrate that demographics (age, race, socioeconomic status), diseases (e.g., diabetes, hypertension, obesity, stress, infection, high altitude), recreational and therapeutic drug use, and chemical exposures are associated with an increased risk for CHD. Unfortunately, although studies suggest that exposures to these factors may cause CHD, in most cases, the data is not strong, is inconclusive, or is contradictory. Although most studies concentrate on the effects of maternal exposure, paternal exposure to some agents can also modify this risk. From a mechanistic standpoint, recent delineation of signaling and genetic controls of cardiac development has revealed molecular pathways that may explain the effects of environmental signals on cardiac morphogenesis and may provide further tools to study the effects of environmental stimuli on cardiac development. For example, environmental factors likely regulate cellular signaling pathways, transcriptional and epigenetic regulation, proliferation, and physiologic processes that can control the development of the heart and other organs. However, understanding of the epidemiology and risk of these exposures and the mechanistic basis for any effects on cardiac development remains incomplete. Further studies defining the relationship between environmental exposures and human CHD and the mechanisms involved should reveal strategies to prevent, diagnose, and treat CHD induced by environmental signals.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Jenkins KJ, Correa A, Feinstein JA et al (2007) Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115:2995–3014
Forrest JM, Turnbull FM, Sholler GF et al (2002) Gregg’s congenital rubella patients 60 years later. Med J Australia 177:664–667
Ferencz C, Loffredo CA, Correa-Villasenor A et al (1997) Genetic and environmental risk factors of major cardiovascular malformations: the Baltimore-Washington Infant Study: 1981–1989, vol 5. Perspectives in pediatric cardiology. Futura Publishing Company, Inc., Armonk
Tikkanen J, Heinonen OP (1990) Risk factors for cardiovascular malformations in Finland. Eur J Epidemiol 6:348–356
Gorini F, Chiappa E, Gargani L et al (2014) Potential effects of environmental chemical contamination in congenital heart disease. Pediatr Cardiol 35:559–568
Patel SS, Burns TL (2013) Nongenetic risk factors and congenital heart defects. Pediatr Cardiol 34:1535–1555
Huybrechts KF, Palmsten K, Avorn J et al (2014) Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med 370:2397–2407
Linask KK, Huhta J (2010) Folate protection from congenital heart defects linked with canonical Wnt signaling and epigenetics. Curr Opin Pediatr 22:561–566
Buscariollo DL, Fang X, Greenwood V et al (2014) Embryonic caffeine exposure acts via A1 adenosine receptors to alter adult cardiac function and DNA methylation in mice. PLoS One 9:e87547
Ewing CK, Loffredo CA, Beaty TH (1997) Paternal risk factors for isolated membranous ventricular septal defects. Am J Med Genet 71:42–46
O’Reilly VC, Lopes Floro K, Shi H et al (2014) Gene-environment interaction demonstrates the vulnerability of the embryonic heart. Dev Biol 391:99–110
Puente BN, Kimura W, Muralidhar SA et al (2014) The oxygen-rich postnatal environment induces cardiomyocyte cell-cycle arrest through DNA damage response. Cell 157:565–579
Al-Gubory KH (2014) Environmental pollutants and lifestyle factors induce oxidative stress and poor prenatal development. Reprod Biomed Online 29:17–31
Wagner M, Siddiqui MA (2007) Signal transduction in early heart development (II): ventricular chamber specification, trabeculation, and heart valve formation. Exp Biol Med 232:866–880
Asrih M, Steffens S (2013) Emerging role of epigenetics and miRNA in diabetic cardiomyopathy. Cardiovasc Pathol 22:117–125
Hom JR, Quintanilla RA, Hoffman DL et al (2011) The permeability transition pore controls cardiac mitochondrial maturation and myocyte differentiation. Dev Cell 21:469–478
Zaidi S, Choi M, Wakimoto H et al (2013) De novo mutations in histone-modifying genes in congenital heart disease. Nature 498:220–223
Patterson AJ, Chen M, Xue Q et al (2010) Chronic prenatal hypoxia induces epigenetic programming of PKC-epsilon gene repression in rat hearts. Circ Res 107:365–373
Baccarelli A, Ghosh S (2012) Environmental exposures, epigenetics and cardiovascular disease. Curr Opin Clin Nutr 15:323–329
Csoka AB, Szyf M (2009) Epigenetic side-effects of common pharmaceuticals: a potential new field in medicine and pharmacology. Med Hypotheses 73:770–780
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Wien
About this chapter
Cite this chapter
Porter, G.A. (2016). Environmental Signals. In: Rickert-Sperling, S., Kelly, R., Driscoll, D. (eds) Congenital Heart Diseases: The Broken Heart. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1883-2_16
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1883-2_16
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1882-5
Online ISBN: 978-3-7091-1883-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)